MARKET

XTLB

XTLB

Xtl Biopharmaceu
NASDAQ
0.6040
+0.0240
+4.14%
Opening 14:02 01/02 EST
OPEN
0.5800
PREV CLOSE
0.5800
HIGH
0.6100
LOW
0.5301
VOLUME
307.06K
TURNOVER
--
52 WEEK HIGH
2.570
52 WEEK LOW
0.5301
MARKET CAP
5.32M
P/E (TTM)
-0.9895
1D
5D
1M
3M
1Y
5Y
1D
XTL Biopharmaceuticals Takes Major Impairment on The Social Proxy in First-Half 2025 Results
TipRanks · 12/30/2025 19:57
XTL Biopharmaceuticals Faces Nasdaq Bid-Price Deficiency, Given Until June 2026 to Regain Compliance
TipRanks · 12/29/2025 21:41
XTL Biopharmaceuticals Faces Nasdaq Delisting Risk Over Minimum Bid Price Deficiency
Reuters · 12/29/2025 21:06
Weekly Report: what happened at XTLB last week (1222-1226)?
Weekly Report · 12/29/2025 10:12
XTL Biopharmaceuticals receives Nasdaq bid price deficiency notice
Seeking Alpha · 12/24/2025 21:33
XTL Biopharmaceuticals Faces Nasdaq Delisting Risk Over Minimum Bid Price Deficiency
Reuters · 12/24/2025 21:00
XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
Barchart · 12/24/2025 15:00
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 12/23/2025 21:05
More
About XTLB
X T L Biopharmaceuticals Ltd (Xenograft Technologies Ltd) is an Israel-based biopharmaceutical company engaged in acquisition and development of pharmaceutical drugs for treatment of autoimmune diseases. The Company pipelines include hCDR1 systematic lupus erythematosus and recombinant human erythropoietin (rHuEPO) multiple myeloma. Its hCDR1, which is a potential treatment for systemic lupus erythematosus (SLE) and Sjogren's syndrome (SS). hCDR1 is a peptide that is administered subcutaneously and acts as a disease-specific treatment to modify the SLE-related autoimmune process. The rHuEPO known agent for anemia to prolong a survival of patients for treatment of multiple myeloma blood cancer. Its Erythropoietin (EPO) is a glycoprotein hormone produced mainly by kidneys. EPO stimulates erythropoiesis, production of red blood cells, by binding to its receptor on a surface of erythroid progenitor cells, promoting their proliferation and differentiation and maintaining their viability.

Webull offers X T L Biopharmaceuticals Ltd (ADR) stock information, including NASDAQ: XTLB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XTLB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XTLB stock methods without spending real money on the virtual paper trading platform.